“Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer” (2013) Journal of Analytical Oncology, 2(3), pp.  151–159. doi:10.6000/1927-7229.2013.02.03.4.